MOH News
Jeddah: Over 25,000 patients Served by King Abdullah Medical City
17 April 2018

​King Abdullah Medical Complex- Jeddah, from January to March 2018, served 25,695 patients at the outpatient clinics, who benefited from the therapeutic services at different medical departments. The patients were either transferred from the complex's primary healthcare centers or from inpatient or emergency departments.

 

According to statistics, specialized medical services clinics served around 500 patients per a day in various specialties, including orthopedics, neurosurgery, ENT and abdominal surgery. The complex's clinics feature 33 medical specialties at 79 clinics equipped with the cutting-edge appliances.

It is noted that the work is underway to develop the outpatient clinics with the aim of reducing patients' waiting lists. Also, the number of outpatients increased by 46% compared to the first quarter of 2017.
On the other hand, the Ministry of Health (MOH) has recently started implementing the second phase of the National Program for Hepatitis C Virus (HCV) Detection and Treatment. As well, MOH has launched an awareness campaign entitled (Give Your Hand), which features several awareness materials to be posted on social media. “During the past two years, MOH has provided a number of quality drugs to treat HCV, while giving priority to sophisticated cases or those transmitting infections to other. The introduction of locally produced world-class drugs has help expand the scope of treatment in an unprecedented way; thus, removing priority barriers. In addition, the Program trains both doctors and coordinators, and provides lab and radiology test, as well as the logistic services needed for its implementation.

It is noteworthy that hepatitis C virus (HCV) causes both acute and chronic infection. Acute HCV infection is usually asymptomatic. About 15–30% of infected persons spontaneously clear the virus. The remaining will develop chronic HCV infection, which may lead to cirrhosis or liver cancer in some cases. HCV can be cured using new direct-acting antiviral medicines recently made available, which have proven effective with more than 95% recovery percentage. However, there is no vaccine for hepatitis C.





Content Evaluation
Reading times
Last Update 22 April 2018 11:12 AM
Do you find this content useful? Yes No Suggest
Satisfaction of visitorsA sign of happiness
Satisfaction of visitors Completely satisfied Satisfied Neutral Not Satisfied Completely dissatisfied
This site can be viewed on all screen tones and all smart devices and supports all kinds of browsers
All Rights Reserved – Ministry of Health – Kingdom of Saudi Arabia ©